A multicenter study to evaluate the impact of circulating tumor DNA guided therapy (BESPOKE) in patients with stage II and III colorectal cancer

被引：2
|
作者：
Kasi, P. M. [1 ]
Sawyer, S. [2 ]
Guilford, J. [2 ]
Munro, M. [2 ]
Ellers, S. [2 ]
Hook, N. [2 ]
Krinshpun, S. [2 ]
Moshkevich, S. [2 ]
Billings, P. R. [2 ]
Aleshin, A. [2 ]
机构：
[1] Univ Iowa Hlth Care, Internal Med, Iowa City, IA USA
[2] Natera Inc, Oncol, San Carlos, CA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.630
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
520TiP
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [1] BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer
    Kasi, Pashtoon Murtaza
    Sawyer, Sarah
    Guilford, Jessica
    Munro, Michelle
    Ellers, Sascha
    Wulff, Jacob
    Hook, Nicole
    Krinshpun, Shifra
    Malashevich, Allyson Koyen
    Malhotra, Meenakshi
    Rodriguez, Angel
    Moshkevich, Solomon
    Grothey, Axel
    Kopetz, Scott
    Billings, Paul
    Aleshin, Alexey
    BMJ OPEN, 2021, 11 (09):
  • [2] Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study.
    Kasi, Pashtoon Murtaza
    Aushev, Vasily N.
    Ensor, Joe
    Langer, Nathan
    Wang, Christopher Gene
    Cannon, Timothy Lewis
    Berim, Lyudmyla Derby
    Feinstein, Trevor
    Grothey, Axel
    McCollom, Joseph William
    Kalmadi, Sujith R.
    Zakari, Ahmed
    Dayyani, Farshid
    Gravenor, Donald
    Meyer, Janelle Marie
    Sharif, Saima
    Jurdi, Adham A.
    Liu, Minetta C.
    Aleshin, Alexey
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 9 - 9
  • [3] Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
    Zhu, Ning
    Hu, Hanguang
    Yuan, Ying
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [4] Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer
    Ning Zhu
    Hanguang Hu
    Ying Yuan
    Signal Transduction and Targeted Therapy, 7
  • [5] Circulating tumor DNA as a marker of recurrence risk in stage III colorectal cancer: The α-CORRECT study
    Schoen, Robert E.
    Diergaarde, Brenda
    Young, Gregory
    Hall, David W.
    Marti, Tara
    Mazloom, Amin
    Costa, Gina
    Subramaniam, Somasundaram
    Palomares, Melanie R.
    Garces, Jorge
    Baehner, Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 302 - 302
  • [6] Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT Study
    Diergaarde, Brenda
    Young, Greg
    Hall, David W.
    Mazloom, Amin
    Costa, Gina L.
    Subramaniam, Soma
    Palomares, Melanie R.
    Garces, Jorge
    Baehner, Frederick L.
    Schoen, Robert E.
    xact Sciences MRD Group
    JOURNAL OF SURGICAL ONCOLOGY, 2025,
  • [7] Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS)
    Benhaim, Leonor
    Bouche, Olivier
    Normand, Corinne
    Didelot, Audrey
    Mulot, Claire
    Le Corre, Delphine
    Garrigou, Sonia
    Djadi-Prat, Juliette
    Wang-Renault, Shu-Fang
    Perez-Toralla, Karla
    Pekin, Deniz
    Poulet, Geoffroy
    Landi, Bruno
    Taieb, Julien
    Selvy, Marie
    Emile, Jean-Francois
    Lecomte, Thierry
    Blons, Helene
    Chatellier, Gilles
    Link, Darren R.
    Taly, Valerie
    Laurent-Puig, Pierre
    EUROPEAN JOURNAL OF CANCER, 2021, 159 : 24 - 33
  • [8] Impact of Infectious Complications on Survival and Recurrence of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective Study
    Tamagawa, Hiroshi
    Aoyama, Toru
    Numata, Masakatsu
    Kazama, Keisuke
    Atsumi, Yosuke
    Iguchi, Kenta
    Ju, Mihwa
    Sawazaki, Sho
    Sato, Sumito
    Kano, Kazuki
    Ohshima, Takashi
    Yamada, Takanobu
    Godai, Teni
    Higuchi, Akio
    Saeki, Hiroyuki
    Yukawa, Norio
    Rino, Yasushi
    ANTICANCER RESEARCH, 2022, 42 (05) : 2763 - 2769
  • [9] Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective Study
    Tamagawa, Hiroshi
    Numata, Masakatsu
    Aoyama, Toru
    Kazama, Keisuke
    Atsumi, Yosuke
    Iguchi, Kenta
    Sawazaki, Sho
    Sato, Sumito
    Kano, Kazuki
    Ohshima, Takashi
    Yamada, Takanobu
    Godai, Teni
    Higuchi, Akio
    Saeki, Hiroyuki
    Yukawa, Norio
    Rino, Yasushi
    IN VIVO, 2021, 35 (06): : 3483 - 3488
  • [10] Circulating tumor DNA for detection of molecular residual disease (MRD) in patients (pts) with stage II/III colorectal cancer (CRC): Final analysis of the BESPOKE CRC sub-cohort.
    Shah, Purvi K.
    Aushev, Vasily N.
    Ensor, Joe
    Sanchez, Stephanie A.
    Wang, Christopher Gene
    Cannon, Timothy Lewis
    Berim, Lyudmyla Derby
    Feinstein, Trevor
    Grothey, Axel
    McCollom, Joseph William
    Kalmadi, Sujith R.
    Zakari, Ahmed
    Dayyani, Farshid
    Gravenor, Don
    Liu, Minetta C.
    Jurdi, Adham A.
    Aleshin, Alexey
    Meyer, Janelle Marie
    Sharif, Saima
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 15 - 15
12345